14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of TM5.F
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

T-Mobile US, Inc. stock price down 0.0666% on Thursday
(Updated on May 16, 2024)

Buy or Hold candidate since May 02, 2024 Loss -2.52% PDF

The T-Mobile US, Inc. stock price fell by -0.0666% on the last day (Thursday, 16th May 2024) from 150.24€ to 150.14€. It has now fallen 4 days in a row. During the last trading day the stock fluctuated 0.334% from a day low at 149.64€ to a day high of 150.14€. The price has fallen in 8 of the last 10 days and is down by -2.52% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -11 shares and in total, 20 shares were bought and sold for approximately 3.00€ thousand.

The stock is moving within a narrow and horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect T-Mobile US, Inc. stock with a 90% probability to be traded between 149.70€ and 156.07€ at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

TM5.F Signals & Forecast

There are few to no technical positive signals at the moment. The T-Mobile US, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at 151.26€ and 150.92€. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, May 02, 2024, and so far it has fallen -2.52%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued. The stock had a Golden Star Signal on Thursday, April 11, 2024 in the short-term chart.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.

Buy
Special Signal Notification

Golden Star

The stock had a Golden Star Signal on Thursday, April 11, 2024 in the short-term chart.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.
Buy
Special Signal Notification

Double Bottom Formation

Double Bottom Formation A buy signal from a double bottom formation was found on Tuesday, April 09, 2024 and based on theory for this formation the price should go up by 2.57% to 154.00€ within 11 trading days since signal was issued (Friday, May 17, 2024).

Support, Risk & Stop-loss for T-Mobile US, Inc. stock

T-Mobile US, Inc. finds support from accumulated volume at 149.96€ and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved 0.500€ between high and low, or 0.334%. For the last week the stock has had daily average volatility of 0.562%

Our recommended stop-loss: 143.14€ (-4.66%) (This stock has low daily movements and this gives low risk. There is a sell signal from a pivot top found 10 days ago.)

Trading Expectations (TM5.F) For The Upcoming Trading Day Of Friday 17th

For the upcoming trading day on Friday, 17th we expect T-Mobile US, Inc. to open at 149.97€, and during the day (based on 14 day Average True Range), to move between 148.67€ and 151.61€, which gives a possible trading interval of +/-1.47€ (+/-0.98%) up or down from last closing price. If T-Mobile US, Inc. takes out the full calculated possible swing range there will be an estimated 1.96% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at 149.96€ (0.12%) than the resistance at 150.44€ (0.20%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is T-Mobile US, Inc. stock A Buy?

T-Mobile US, Inc. holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.305 Hold/Accumulate Unchanged

Predicted Opening Price for T-Mobile US, Inc. of Friday, May 17, 2024

Fair opening price May 17, 2024 Current price
149.97€ ( 0.111%) 150.14€

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for TM5.F

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 150.47 0.222 %
R2 150.28 0.0948 %
R1 150.16 0.0162 %
Current price: 150.14
Support S1 149.78 -0.238 %
S2 149.66 -0.317 %
S3 149.47 -0.444 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 150.82 0.453 %
R2 150.54 0.266 %
R1 150.44 0.200 %
Current price 150.14
Support S1 149.96 -0.120%
S2 148.72 -0.95%
S3 148.42 -1.15%

TM5 Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 May 31, 2024 May 31, 2024 Jun 13, 2024 0.607€ 0%
2 May 30, 2024 May 30, 2024 Jun 13, 2024 0.597€ 0%
3 Feb 29, 2024 Feb 29, 2024 Mar 14, 2024 0.597€ 0%
4 Nov 30, 2023 Nov 30, 2023 Nov 30, 2023 0.650€ 0%

FAQ

What is the symbol for T-Mobile US, Inc. Stock and on which exchange is it traded?
The symbol for T-Mobile US, Inc. is TM5.F and it is traded on the FRA (Frankfurt Stock Exchange).

Should I buy or sell T-Mobile US, Inc. Stock?
T-Mobile US, Inc. holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy T-Mobile US, Inc. Stock?
T-Mobile US, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy T-Mobile US, Inc. Stock.

What's the current price of T-Mobile US, Inc. Stock?
As of the end of day on the May 16, 2024, the price of an T-Mobile US, Inc. (TM5.F) share was 150.14€.

What is the 52-week high and low for T-Mobile US, Inc. Stock?
The 52-week high for T-Mobile US, Inc. Stock is 155.80€ and the 52-week low is 117.40€.

What is the market capitalization of T-Mobile US, Inc. Stock?
As of the May 16, 2024, the market capitalization of T-Mobile US, Inc. is 177.207B.

When is the next earnings date for T-Mobile US, Inc.?
The upcoming earnings date for T-Mobile US, Inc. is Jul 25, 2024.
Click to get the best stock tips daily for free!

About T-Mobile US, Inc.

T-Mobile US. Aileron Therapeutics, Inc. operates as a clinical stage chemoprotection oncology company in the United States. The company is developing ALRN-6924, which is in Phase 1 trial for solid tumor and lymphoma; Phase 2a clinical trial to treat peripheral T-cell lymphoma; Phase I clinical trial for the treatment of acute myeloid leukemia (AML) and advanced myelodysplastic syndrome (MDS); Phase 1b trial to test the combination of ALRN-6924 and cytarabine,... TM5.F Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT